|
市場調査レポート
商品コード
1629591
全エクソームシーケンス市場：製品タイプ別、技術別、用途別、適応症別、エンドユーザー別、地域別Whole Exome Sequencing Market, By Product Type, By Technology, By Application, By Indication, By End User, By Geography |
||||||
カスタマイズ可能
|
|||||||
| 全エクソームシーケンス市場：製品タイプ別、技術別、用途別、適応症別、エンドユーザー別、地域別 |
|
出版日: 2024年12月04日
発行: Coherent Market Insights
ページ情報: 英文 145 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 目次
世界の全エクソームシーケンス市場は、2024年に18億米ドルと推定され、2024年から2031年までのCAGRは14.8％を示し、2031年には47億2,000万米ドルに達すると予測されます。
| レポート範囲 | レポート詳細 | ||
|---|---|---|---|
| 基準年 | 2023 | 2024年の市場規模 | 18億米ドル |
| 実績データ | 2019年から2023年まで | 予測期間 | 2024年から2031年まで |
| 予測期間2024年から2031年 CAGR： | 14.80% | 2031年の価値予測 | 47億2,000万米ドル |
全エクソームシーケンスは、疾患の原因となる遺伝的変異を検出するために、遺伝子のタンパク質コード領域全体を分析できる強力な技術です。近年、臨床診断と遺伝子研究に革命をもたらしています。全エクソームシーケンス市場は、がん研究におけるアプリケーションの増加、個別化医療に対する需要の増加、従来のシーケンス技術に対する全ゲノムシーケンスの人気の高まりにより、大きな成長が見込まれています。
市場力学：
世界の全エクソームシーケンス市場は、慢性疾患の罹患率の上昇、研究活動への資金提供の増加、創薬における全エクソームシーケンスの適用範囲の拡大、精密医療によって牽引されています。しかし、予算の制約、熟練した人材の必要性、適切な償還政策が利用できないことが市場の成長を制限しています。市場は、新興国、継続的な技術進歩、産学連携の増加により、プレーヤーに機会を提供しています。
本調査の主な特徴
当レポートでは、世界の全エクソームシーケンス市場を詳細に分析し、2023年を基準年とした予測期間（2024年～2031年）の市場規模（10億米ドル）と年間平均成長率（CAGR%）を掲載しています。
また、さまざまなセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案のマトリックスについて説明しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の全エクソームシーケンス市場の主要企業をプロファイルしています。
本調査の対象となる主要企業には、Illumina, Inc.、Thermo Fisher Scientific Inc.、BGI Genomics、Agilent Technologies, Inc.、Roche Diagnostics、QIAGEN N.V.、Pacific Biosciences of California, Inc.、Oxford Nanopore Technologies plc、Eurofins Scientific SE、Genomatix GmbH、Myriad Genetics, Inc.、Bio-Rad Laboratories, Inc.、F. Hoffmann-La Roche Ltd.、Laboratory Corporation of America Holdings、Novogene Corporationなどがあります。
本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発表、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができるようになります。
世界の全エクソームシーケンス市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
利害関係者は、世界の全エクソームシーケンス市場の分析に使用される様々な戦略マトリックスを通じて意思決定を容易にすることができます。
目次
第1章 調査の目的と前提条件
- 調査目的
- 前提条件
- 略語
第2章 市場の展望
- レポートの説明
- 市場の定義と範囲
- エグゼクティブサマリー
第3章 市場力学、規制、動向分析
- 市場力学
- 影響分析
- 主な発展
- 規制シナリオ
- 製品の発売/承認
- PEST分析
- PORTERの分析
- 合併と買収のシナリオ
- 業界動向
第4章 世界の全エクソームシーケンス市場、製品タイプ別、2019年-2031年
- 機器
- 消耗品
- サービス
第5章 世界の全エクソームシーケンス市場、技術別、2019年-2031年
- 合成による配列決定
- イオン半導体シーケンシング
- その他の技術
第6章 世界の全エクソームシーケンス市場、用途別、2019年-2031年
- 医薬品の発見と開発
- 臨床診断
- 調査
第7章 世界の全エクソームシーケンス市場、適応症別、2019年-2031年
- がん
- 希少疾患/遺伝性疾患
- 感染症
- 心血管疾患
- 神経疾患
- その他
第8章 世界の全エクソームシーケンス市場、エンドユーザー別、2019年-2031年
- 病院・クリニック
- 診断研究所
- 学術調査機関
- バイオ医薬品企業
第9章 世界の全エクソームシーケンス市場、地域別、2019年-2031年
- 北米
- ラテンアメリカ
- 欧州
- アジア太平洋
- 中東
- アフリカ
第10章 競合情勢
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- BGI Genomics
- Agilent Technologies, Inc.
- Roche Diagnostics
- QIAGEN N.V.
- Pacific Biosciences of California, Inc.
- Oxford Nanopore Technologies plc
- Eurofins Scientific SE
- Genomatix GmbH
- Myriad Genetics, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd
- Laboratory Corporation of America Holdings
- Novogene Corporation
第11章 アナリストの推奨事項
- 運命の輪
- アナリストの見解
- 一貫した機会マップ
第12章 参考文献と調査手法
- 参考文献
- 調査手法
- 出版社について
The global whole exome sequencing market is estimated to be valued at USD 1.80 Bn in 2024 and is expected to reach USD 4.72 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 14.8% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 1.80 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 14.80% | 2031 Value Projection: | US$ 4.72 Bn |
Whole exome sequencing is a powerful technology that allows analyzing the entire protein-coding region of genes in order to detect genetic variations responsible for diseases. It has revolutionized clinical diagnosis and genetic research in recent years. Whole exome sequencing market is expected to experience significant growth due to rising applications in cancer research, increasing demand for personalized medicine, and growing popularity of whole genome sequencing over traditional sequencing techniques.
Market Dynamics:
The global whole exome sequencing market is driven by rising incidence of chronic diseases, increased funding for research activities, growing applicability of whole exome sequencing in drug discovery, and precision medicine. However, budget constraints, requirement of skilled personnel and non-availability of adequate reimbursement policies limit the market growth. The market provides opportunities for players due to emerging economies, continuous technological advancements, and increasing collaborations between industry and academia.
Key Features of the Study:
This report provides in-depth analysis of the global whole exome sequencing market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global whole exome sequencing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Illumina, Inc., Thermo Fisher Scientific Inc., BGI Genomics, Agilent Technologies, Inc., Roche Diagnostics, QIAGEN N.V., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies plc, Eurofins Scientific SE, Genomatix GmbH, Myriad Genetics, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings, and Novogene Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global whole exome sequencing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global whole exome sequencing market
Market Segmentation
- By Product Type Insights (Revenue, USD Bn, 2019 - 2031)
- Instruments
- Consumables
- Services
- By Technology Insights (Revenue, USD Bn, 2019 - 2031)
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Other Technologies
- By Application Insights (Revenue, USD Bn, 2019 - 2031)
- Drug Discovery & Development
- Clinical Diagnostics
- Research
- By Indication Insights (Revenue, USD Bn, 2019 - 2031)
- Cancer
- Rare/Inherited Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Others
- By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals & Clinics
- Diagnostics Laboratories
- Academic and Research Institutes
- Biopharmaceutical Companies
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- BGI Genomics
- Agilent Technologies, Inc.
- Roche Diagnostics
- QIAGEN N.V.
- Pacific Biosciences of California, Inc.
- Oxford Nanopore Technologies plc
- Eurofins Scientific SE
- Genomatix GmbH
- Myriad Genetics, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd
- Laboratory Corporation of America Holdings
- Novogene Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Whole Exome Sequencing Market, By Product Type
- Global Whole Exome Sequencing Market, By Technology
- Global Whole Exome Sequencing Market, By Application
- Global Whole Exome Sequencing Market, By Indication
- Global Whole Exome Sequencing Market, By End User
- Global Whole Exome Sequencing Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Whole Exome Sequencing Market, By Product Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Whole Exome Sequencing Market, By Technology, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Sequencing by Synthesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Ion Semiconductor Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Other Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Whole Exome Sequencing Market, By Application, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Drug Discovery & Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Clinical Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Whole Exome Sequencing Market, By Indication, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Rare/Inherited Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Whole Exome Sequencing Market, By End User, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Diagnostics Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Whole Exome Sequencing Market, By Region, 2019 - 2031, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BGI Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies, Inc.
- Roche Diagnostics
- QIAGEN N.V.
- Pacific Biosciences of California, Inc.
- Oxford Nanopore Technologies plc
- Eurofins Scientific SE
- Genomatix GmbH
- Myriad Genetics, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd
- Laboratory Corporation of America Holdings
- Novogene Corporation
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
